Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Nurses screen patients for COVID-19 virus testing at a drive-up location outside Medstar St. Mary's Hospital on March 17, 2020 in Leonardtown, Maryland. Photo: Win McNamee/Getty Images

Pharma company Bayer will soon make a large donation to the U.S. government of a drug that has shown some promise in helping patients suffering from the novel coronavirus, according to a senior Health and Human Services official and another source with direct knowledge.

Why it matters: It doesn't hurt to have a potential treatment on hand, but we're still a very long way from having an approved, clinically tested treatment for the coronavirus.

The big picture: Early evidence suggests that chloroquine — an inexpensive anti-malarial drug — may work just as well, if not even better, than remdesivir, a drug owned by Gilead, which is undergoing clinical trials for treatment of the coronavirus.

  • A study published in Nature found that "remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro."
  • "Chloroquine shouldn’t be left out of the discussion of candidate COVID-19 therapies and may actually be leading the pack," Raymond James wrote in a research note earlier this month.

Yes, but: This doesn't change the need for massive coronavirus efforts, as there is no proven coronavirus treatment or vaccine.

Go deeper

Trio of Saturday mass shootings rock U.S.

Police officers in New York City's Times Square on Saturday. Photo: David Dee Delgado/Getty Images

The U.S. was hit by mass shootings in New York City's Times Square, a shopping mall in Florida and at a townhome near Baltimore that left four people dead, including the suspected shooter.

The big picture: Since President Biden took office in January, over 700 people have been injured or killed in 139 mass shootings as of late last month.

Scottish first minister vows independence referendum after election win

Scotland's First Minister and leader of the Scottish National Party, Nicola Sturgeon, reacts after being declared the winner of the Glasgow Southside seat at Glasgow counting centre in the Emirates Arena in Glasgow on Friday. Photo: Andy Buchanan /AFP via Getty Images

Scotland's First Minister Nicola Sturgeon announced plans Saturday for a second independence referendum once the pandemic has abated following the country's parliamentary elections.

The big picture: Sturgeon's Scottish National Party won 64 seats, one seat short of an outright majority in the 129-seat Parliament. But most seats went to pro-independence parties.

4 hours ago - World

India records its deadliest day of the pandemic

A health worker moving an oxygen cylinder in a coronavirus ward of a hospital in New Delhi on May 8. Photo: Raj K Raj/Hindustan Times via Getty Images

India saw its deadliest day of the pandemic yet with more than 4,180 confirmed COVID-19 deaths reported Saturday.

Why it matters: The country has recorded more than 21.8 million coronavirus cases and 238,270 deaths since the pandemic began. The true numbers, however, are likely much higher, experts say, as the country battles a continued surge in cases that has left hospitals and health workers overwhelmed.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!